In the last trading session, 4.71 million Protagenic Therapeutics Inc (NASDAQ:PTIX) shares changed hands as the company’s beta touched 0. With the company’s per share price at $0.39 changed hands at -$0.03 or -7.27% during last session, the market valuation stood at $2.92M. PTIX’s last price was a discount, traded about -379.49% off its 52-week high of $1.87. The share price had its 52-week low at $0.18, which suggests the last value was 53.85% up since then. When we look at Protagenic Therapeutics Inc’s average trading volume, we note the 10-day average is 20.49 million shares, with the 3-month average coming to 5.34 million.

Protagenic Therapeutics Inc (NASDAQ:PTIX) trade information

Instantly PTIX was in red as seen at the end of in last trading. With action 72.27%, the performance over the past five days has been green. The company’s shares are showing year-to-date downside of -20.90%, with the 5-day performance at 72.27% in the green. However, in the 30-day time frame, Protagenic Therapeutics Inc (NASDAQ:PTIX) is 6.13% up. Looking at the short shares, we see there were 0.19 million shares sold at short interest cover period of 0.03 days.

Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of -10.56%.

PTIX Dividends

Protagenic Therapeutics Inc is expected to release its next quarterly earnings report in May.

Protagenic Therapeutics Inc (NASDAQ:PTIX)’s Major holders

If we look at who the major shareholders are, we find that insiders hold 12.92% of Protagenic Therapeutics Inc shares while 5.18% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 5.95%.